Pacira BioSciences, Inc. (PCRX): EPS (Basic)
$0.16
Year ended 2025-12-31
-23.0%
3-year compound annual growth
-45.8%
5-year compound annual growth
+12.3%
10-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.16 | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$2.15 | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $0.91 | +160.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $0.35 | -63.2% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $0.95 | -72.1% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $3.41 | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$0.27 | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$0.01 | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$1.07 | n/m | 2018-02-28, From 2017-01-01 |
| 2016-12-31 | -$1.02 | n/m | 2018-02-28, From 2016-01-01 |
| 2015-12-31 | $0.05 | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$0.39 | n/m | 2016-02-25, From 2014-01-01 |
| 2013-12-31 | -$1.93 | n/a | 2016-02-25, From 2013-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $0.16 | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $2.10 | -36.2% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$0.68 | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $0.98 | n/m |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $0.95 | -29.6% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $0.80 | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.98 | -7.5% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$5.83 | n/m |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | -$3.68 | n/m |
Compare PCRX, AMPH, SUPN, EBS side by side · Screen every company in Pharmaceutical Preparations ↗